Pfizer running COVID-19 human vaccine trials
The vaccine carries a genetic code known as messenger RNA. It attempts to reprogram the virus rather than manipulate the live virus.
•
May 6, 2020, 10:17 AM
•
Updated 1,629 days ago
Share:
Pfizer and New York University are working on a vaccine for COVID-19.
The vaccine carries a genetic code known as messenger RNA. It attempts to reprogram the virus rather than manipulate the live virus.
Researchers hope the body's immune system will then kick in, creating the antibodies needed to fight off COVID-19.
The group started testing the vaccine on people this week.
This is phase one of the trial, but if proven safe, Pfizer said it could make 20 million doses by the end of the year.
More from News 12
1:59
William Floyd School Board holds emergency closed door meeting following student gun arrest
1:38
Very warm temps continue for another day; more seasonable weather returns Wednesday night
2:18
Massapequa homeowners concerned about reimbursements from PSEG after power surge
0:27
Police: Bethpage man assaulted firefighter assessing damage to his home following crash
2:00
Authorities warn thrill-seekers to stay away from former Kings Park Psychiatric Center
1:35
